Pembrolizumab as maintenance therapy for malignant rhabdoid tumor.

Offenbacher, Rachel; Fabish, Lara; Oliver-Krasinski, Jennifer; Loeb, David M; Baker, Alissa

Offenbacher, Rachel; Fabish, Lara; Oliver-Krasinski, Jennifer; Loeb, David M; Baker, Alissa.

Afiliación

Offenbacher R; Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York, USA.
Fabish L; Division of Pediatric Hematology, Oncology and Cellular Therapy, Children's Hospital at Montefiore, Bronx, New York, USA.
Oliver-Krasinski J; Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York, USA.
Loeb DM; Division of Pediatric Hematology, Oncology and Cellular Therapy, Children's Hospital at Montefiore, Bronx, New York, USA.
Baker A; Department of Pathology, Montefiore Medical Center, Bronx, New York, USA.

Pediatr Blood Cancer ; 69(10): e29660, 2022 10.

Article en En | MEDLINE | ID: mdl-35278029

Asunto(s)

Tumor Rabdoide; Anticuerpos Monoclonales Humanizados/uso terapéutico; Humanos; Tumor Rabdoide/tratamiento farmacológico; Tumor Rabdoide/patología; Proteína SMARCB1

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tumor Rabdoide Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google